Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Return on Assets for 15 consecutive years, with 0.08% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 59.0% to 0.08% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.08%, a 59.0% increase, with the full-year FY2024 number at 0.08%, up 93.0% from a year prior.
  • Return on Assets was 0.08% for Q3 2025 at Gyre Therapeutics, up from 0.06% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.31% in Q1 2023 to a low of 2.91% in Q3 2023.
  • A 5-year average of 0.68% and a median of 0.54% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: crashed -312bps in 2023, then soared 240bps in 2024.
  • Gyre Therapeutics' Return on Assets stood at 1.31% in 2021, then surged by 105bps to 0.06% in 2022, then tumbled by -2385bps to 1.35% in 2023, then skyrocketed by 111bps to 0.15% in 2024, then crashed by -43bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Return on Assets are 0.08% (Q3 2025), 0.06% (Q2 2025), and 0.07% (Q1 2025).